Searchable abstracts of presentations at key conferences in endocrinology

ea0063p672 | Pituitary and Neuroendocrinology 2 | ECE2019

The management of acromegaly: experience of the endocrinology

Elmehraoui Ouafae , Lazreg Youssef , Latrech Hanane

Introduction: Acromegaly is a rare and misdiagnosed disease characterized by somatotropic hypersecretion. The purpose of this study is to describe the epidemiological, clinical, para-clinical, therapeutic features of Acromegaly disease.Patients and methods: This is a retrospective study including 10 patients with acromegaly in the Endocrinology Diabetology Department of Oujda’s Mohammed VI University Hospital, Morocco.Results:...

ea0063p754 | Thyroid 2 | ECE2019

Hyperthyroidism revealed by pulmonary embolism: a case report

Draoui Najat , Assarrar Imane , Latrech Hanane

Introduction: Pre-thrombotic states may be primary, related to a hereditary coagulation disorder or secondary (venous stasis or drug intake). We report a case of hyperthyroidism revealed by pulmonary embolism.Observation: A 82-year-old woman, with a forty years history of type 2 diabetes mellitus, was admitted to the emergency room in a respiratory distress condition. The clinical examination found a dyspnoeic patient with tachycardia, hypertension, and ...

ea0063p777 | Thyroid 2 | ECE2019

Lipid profile in primary hypothyroidism: a comparative study between genders in the Endocrinology-Diabetology-Nutrition Department of Oujda’s University Hospital in Morocco

Assarrar Imane , Draoui Najat , Latrech Hanane

Introduction: Hypothyroidism can be responsible for lipid abnormalities, which increases the risk of cardiovascular diseases and even morbi-mortality. The aim of this study is to analyze the lipid profile in patients with primary hypothyroidism while comparing between genders.Materials and methods: It is a retrospective and comparative study conducted on 57 patients with primary hypothyroidism in the Department of Endocrinology-Diabetology-Nutrition of O...

ea0063ep98 | Pituitary and Neuroendocrinology | ECE2019

Effectiveness of somatostatin analogues in the treatment of acromegaly

Elmehraoui Ouafae , Lazreg Youssef , Latrech Hanane

Introduction: Somatostatinanalogues (SSAs) are the largest contributor to the direct medical cost of acromegaly management worldwide. The aim of this review was to expose our experience and report available evidence on the effectiveness of SSAs in the treatment of acromegaly.Methods: This is a retrospective study including ten acromegalic patients followed in the Endocrinology - Diabetology Department at Mohamed VI University Hospital in Oujda, Morocco.<...

ea0063ep131 | Reproductive Endocrinology | ECE2019

Secondary amenorrhea: epidemiological, clinical and etiology profile at the university hospital center Mohammed VI Oujda

Mahroug Ikram , Elmir Siham , Latrech Hanane

Secondary amenorrhea is defined as the cessation of regular menses for three months or the cessation of irregular menses for six months (1). Most cases of secondary amenorrhea can be attributed to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, or primary ovarian insufficiency the aim of this study to analyze the clinical, biological, etiological profile of secondary amenorrhea (2).Patients and methods: We conducted a retrospectiv...

ea0099ep1330 | Late Breaking | ECE2024

Primary hyperparathyroidism related to mediastinal ectopic parathyroid adenoma: about 2 cases

Zarraa Lamiae , Rouf Siham , Latrech Hanane

Introduction: Primary hyperparathyroidism is a frequent endocrinopathy characterized by a disorder of phosphocalcic metabolism related to an inappropriate secretion of parathyroid hormone (PTH). Parathyroid adenoma can be located ectopically and represents a particular diagnostic and therapeutic challenge. We report 2 clinical cases of ectopic parathyroid adenoma in mediastinal location.Observations: Case 1: A 47-year-old patient without...

ea0081ep163 | Calcium and Bone | ECE2022

Primary hyperparathyroidism: what is the impact on bone ?

Zarraa Lamiae , Berrabeh Soumiya , Laalaoua Yousra , ROUF Siham , Latrech Hanane

Key words: Primary hyperparathyroidism-PTH level –osteoporosis-osteolytic bone lesions-brown tumorIntroduction: Primary hyperparathyroidism is a frequent pathology responsible for an alteration of the phosphocalcic metabolism at the origin of numerous complications, in particular osseous. The objective of this work is to evaluate the bone impact of primary hyperparathyroidism in our series.Matériel et m&#...

ea0081ep167 | Calcium and Bone | ECE2022

Classical complications of primary hyperparathyroidism

Zarraa Lamiae , Laalaoua Yousra , Berrabeh Soumiya , ROUF Siham , Latrech Hanane

Key words: Primary hyperparathyroidsm-Bone complications-Renal complications and digestive complications.IntroductionPrimary hyperparathyroidism is a frequent endocrinopathy whose diagnosis is biological and linked to an inappropriate secretion of parathyroid hormone (PTH), wich leads to an altered phosphocalcic metabolism that can be responsible for numerous complications. The aim of this work is to evaluate the classical complica...

ea0081ep711 | Pituitary and Neuroendocrinology | ECE2022

Pituitary adenoma in the young adult

Zarraa Lamiae , Wahiba Abdellaoui , Assarrar Imane , Rouf Siham , Latrech Hanane

Introduction & Background: Pituitary adenomas represent 10-25% of all intracranial tumors. Their incidence is higher between the ages of 40-60 years and less frequent in young adults. The objective of this work was to evaluate the prevalence as well as the clinical and etiological profile of pituitary adenomas in young adults.Key words : pituitary adenoma- yount adult.Material and methods: Retrospective descriptive study of 21 ...

ea0081ep739 | Pituitary and Neuroendocrinology | ECE2022

Giant pituitary adenomas: about 15 cases

Zarraa Lamiae , Berrabeh Soumiya , Assarrar Imane , ROUF Siham , Latrech Hanane

Key Words: Giant – pituitary adenomaIntroduction & Background: Giant pituitary adenomas are uncommon tumors defined by a tumor diameter ≥ 4 cm. Their prevalence estimated at 6-10% of all pituitary adenomas, whose clinical characteristics and prognosis are not well known. The purpose of this work was to evaluate the prevalence as well as the clinical and evolutionary characteristics of giant pituitary adenomas in our series.<p class="ab...